Clincosm LogoSign in Get a demo

advanced solid tumor

Showing NaN - NaN of 42
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Solid Tumor Trial in Worldwide (Erdafitinib)

Recruiting
  • Advanced Solid Tumor
  • Tucson, Arizona
  • +199 more
Jan 27, 2023

Advanced Solid Tumor Trial in New York (STI-6129)

Not yet recruiting
  • Advanced Solid Tumor
  • STI-6129
  • New York, New York
    Columbia University Medical Center
Jan 26, 2023

Tumor, Tumor, Solid, Metastasis Trial in United States (nab-sirolimus)

Recruiting
  • Tumor
  • +20 more
  • Mobile, Alabama
  • +81 more
Jan 24, 2023

Advanced Solid Tumor, Advanced Lymphoma Trial in Australia, United States (CS5001)

Recruiting
  • Advanced Solid Tumor
  • Advanced Lymphoma
  • East Setauket, New York
  • +9 more
Jan 17, 2023

Advanced Solid Tumor, Metastatic Breast Cancer Trial in United States (Abraxane)

Active, not recruiting
  • Advanced Solid Tumor
  • Metastatic Breast Cancer
  • Gilbert, Arizona
  • +19 more
Jan 13, 2023

Advanced Solid Tumor, Castration-Resistant Prostatic Cancer, Malignant Melanoma Trial in United States (MGC018, lorigerlimab)

Recruiting
  • Advanced Solid Tumor
  • +6 more
  • vobramitamab duocarmazine
  • lorigerlimab
  • Los Angeles, California
  • +7 more
Jan 10, 2023

Advanced Solid Tumor, Malignant Solid Tumor Trial in Japan, United States (DS-7300a)

Recruiting
  • Advanced Solid Tumor
  • Malignant Solid Tumor
  • Los Angeles, California
  • +21 more
Jan 5, 2023

Advanced Solid Tumor, Non Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma Trial in United States (STK-012,

Recruiting
  • Advanced Solid Tumor
  • +10 more
  • Boston, Massachusetts
  • +8 more
Jan 2, 2023

Advanced Solid Tumor, Metastatic Solid Tumor, Urothelial Carcinoma Trial in United States (Lurbinectedin)

Recruiting
  • Advanced Solid Tumor
  • +4 more
  • Stanford, California
  • +15 more
Dec 21, 2022

Advanced Solid Tumor, Gynecologic Cancer Trial in Worldwide (Lucitanib, Nivolumab)

Suspended
  • Advanced Solid Tumor
  • Gynecologic Cancer
  • Los Angeles, California
  • +26 more
Dec 16, 2022

Advanced Solid Tumor Trial in Worldwide (RP-3500, Talazoparib, Gemcitabine Injection [Gemzar])

Recruiting
  • Advanced Solid Tumor
  • Chicago, Illinois
  • +12 more
Nov 18, 2022

Advanced Solid Tumor Trial in Korea, Republic of, United States (hSTC810)

Recruiting
  • Advanced Solid Tumor
  • hSTC810
  • New Haven, Connecticut
  • +4 more
Nov 16, 2022

Advanced Solid Tumor, Head and Neck Squamous Cell Carcinoma, Bladder Carcinoma Trial in Duarte, Iowa City, New York

Recruiting
  • Advanced Solid Tumor
  • +13 more
  • Duarte, California
  • +3 more
Oct 25, 2022

Advanced Solid Tumor, Cutaneous T-cell Lymphoma (CTCL) Trial in United States (SIM1811-03)

Recruiting
  • Advanced Solid Tumor
  • Cutaneous T-cell Lymphoma (CTCL)
  • Detroit, Michigan
  • +5 more
Oct 6, 2022

Advanced Solid Tumor Trial in United Kingdom, United States (CDK-002)

Active, not recruiting
  • Advanced Solid Tumor
  • CDK-002
  • Scottsdale, Arizona
  • +7 more
Sep 27, 2022

Advanced Solid Tumor, DLBCL Trial in United States (RNK05047)

Recruiting
  • Advanced Solid Tumor
  • DLBCL
  • Atlanta, Georgia
  • +3 more
Aug 23, 2022

Advanced Solid Tumor, Clear Cell Renal Cell Carcinoma, Hepatocellular Carcinoma Trial in Korea, Republic of, Singapore, United

Recruiting
  • Advanced Solid Tumor
  • +3 more
  • Duarte, California
  • +22 more
Aug 17, 2022

Advanced Solid Tumor, Advanced Malignant Tumor, Metastatic Cancer Trial in United States (PC14586)

Recruiting
  • Advanced Solid Tumor
  • +3 more
  • Los Angeles, California
  • +10 more
Aug 12, 2022

Mesothelioma, Non Small Cell Lung Cancer, Malignant Peripheral Nerve Sheath Tumors Trial in United States (MRTX1719)

Recruiting
  • Mesothelioma
  • +5 more
  • Denver, Colorado
  • +5 more
Aug 8, 2022

Advanced Solid Tumor, CNS Tumor, Recurrent WHO Grade II Glioma Trial in Canada, Germany, United States (Infigratinib)

Not yet recruiting
  • Advanced Solid Tumor
  • +2 more
  • Palo Alto, California
  • +9 more
Aug 2, 2022

Advanced Solid Tumor Trial in New York, Houston, Salt Lake City (RP-6306 (oral PKMYT1 inhibitor))

Recruiting
  • Advanced Solid Tumor
  • RP-6306 (oral PKMYT1 inhibitor)
  • New York, New York
  • +2 more
Jun 21, 2022

ER+ Breast Cancer, CCNE1 Amplification, HER2-negative Breast Cancer Trial in United States (BLU-222, Carboplatin, Ribociclib)

Recruiting
  • ER+ Breast Cancer
  • +8 more
  • Sarasota, Florida
  • +3 more
Jun 8, 2022

Solid Tumor, Adult, Advanced Solid Tumor, Metastatic Solid Tumor Trial in United Kingdom, United States (Etigilimab dosing,

Recruiting
  • Solid Tumor, Adult
  • +2 more
  • Phoenix, Arizona
  • +15 more
Jun 6, 2022

Low-grade Glioma, Advanced Solid Tumor Trial in Worldwide (DAY101)

Recruiting
  • Low-grade Glioma
  • Advanced Solid Tumor
  • San Francisco, California
  • +35 more
May 25, 2022

Advanced Solid Tumor, PIK3CA Mutation, PTEN Loss of Function Mutation Trial in United States (Serabelisib, Insulin Suppressing

Recruiting
  • Advanced Solid Tumor
  • +2 more
  • Birmingham, Alabama
  • +9 more
May 25, 2022